The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores

Abstract Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell disorders; they are characterized by ineffective hematopoiesis and a predilection to the development of acute myeloid leukemia (AML). For a rapid evaluation of the outcome in myelodysplastic patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Căzăceanu, O, Vlădăreanu, AM, Bumbea, H, Begu, M, Onisai, M, Enache, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233434/
https://www.ncbi.nlm.nih.gov/pubmed/25408750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233434/
https://www.ncbi.nlm.nih.gov/pubmed/25408750

Ejemplares similares